SKIN KAPOSI SARCOMA

Clinical trials for SKIN KAPOSI SARCOMA explained in plain language.

Never miss a new study

Get alerted when new SKIN KAPOSI SARCOMA trials appear

Sign up with your email to follow new studies for SKIN KAPOSI SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

Experimental drug aims to shrink kaposi sarcoma lesions

Disease control Not yet recruiting

This study tests a drug called nirogacestat in 28 people with Kaposi sarcoma (KS) that affects the skin. The drug blocks a protein that helps cancer cells grow, with the goal of shrinking tumors and preventing new ones. While current treatments can help, there is no cure for KS, …

Matched conditions: SKIN KAPOSI SARCOMA

Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control

Last updated May 15, 2026 11:57 UTC

SKIN KAPOSI SARCOMA

Get alerted when new SKIN KAPOSI SARCOMA trials appear

Experimental drug aims to shrink kaposi sarcoma lesions